Kymera Therapeutics, Inc.
SEC CIK 1815442 · KYMR · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Booth Bruce | Director | filed 2020–2026 |
| BVF Partners L P/IL | Director | filed 2020–2026 |
| BVF INC/IL | Director | filed 2020–2026 |
| Biotechnology Value Fund II LP | Director | filed 2020–2026 |
| Lampert Mark N | Director | filed 2020–2026 |
| Biotechnology Value Trading Fund OS LP | Director | filed 2020–2026 |
| BVF Partners OS Ltd. | Director | filed 2020–2026 |
| BVF I GP LLC | Director | filed 2020–2026 |
| BVF II GP LLC | Director | filed 2020–2026 |
| BVF GP Holdings LLC | Director | filed 2020–2026 |
| Biotechnology Value Fund L P | Director | filed 2020–2026 |
| Baker Julian | Director | filed 2024–2026 |
| Baker Felix | Director | filed 2024–2026 |
| Maraganore John | Director | filed 2022–2026 |
| Baker Bros. Advisors LP | Director | filed 2024–2026 |
| Baker Brothers Life Sciences LP | Director | filed 2024–2026 |
| 667, L.P. | Director | filed 2024–2026 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2024–2026 |
| Sandor Victor | Director | filed 2022–2026 |
| Albers Jeffrey W. | Director | filed 2020–2026 |
| Esposito Pamela | Director | filed 2020–2026 |
| Ridloff Elena | Director | filed 2021–2026 |
| Hrustanovic Gorjan | Director | filed 2020–2026 |
| Mainolfi Nello | Director · President and CEO | filed 2020–2026 |
| Morgan Leigh | Director | filed 2022–2024 |
| Horobin Joanna | Director | filed 2020–2024 |
| Nicholson Donald William | Director | filed 2020–2022 |
| Hall Steven Edward | Director | filed 2020–2021 |
| Hedin Andrew | Director | filed 2020–2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Goodman Noah | Chief Business Officer | filed 2025–2026 |
| Jacobs Bruce N. | Chief Financial Officer | filed 2020–2026 |
| Chadwick Jeremy G | Chief Operating Officer | filed 2023–2026 |
| Adams Brian | Chief Legal Officer | filed 2025–2026 |
| Gollob Jared | Chief Medical Officer | filed 2020–2026 |
| Chiniara Ellen | Chief Legal Officer | filed 2023–2025 |
| Caughey Elaine | Chief Business Officer | filed 2021–2023 |
| Chesworth Richard | Chief Scientific Officer | filed 2020–2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.